SAB-176
SAB-176-201
Phase 2 mab completed
Quick answer
SAB-176 for Influenza A H1N1 is a Phase 2 program (mab) at SAB Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SAB Biotherapeutics
- Indication
- Influenza A H1N1
- Phase
- Phase 2
- Modality
- mab
- Status
- completed